ruthenium has been researched along with cyclic gmp in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (66.67) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, H; Morris, RE; Parkinson, JA; Sadler, PJ | 1 |
Bella, J; Habtemariam, A; Sadler, PJ; Wang, F; Xu, J | 1 |
Bendhack, LM; Bonaventura, D; da Silva, RS; Lunardi, CN; Oliveira, FS; Vercesi, JA | 1 |
Eroy-Reveles, AA; Fukuto, JM; Hobbs, AJ; Madhani, M; Mascharak, PK; Miller, TW; Patra, AK | 1 |
Ding, XL; Ge, HY; Jiang, H; Ning, LP; Wang, R; Wang, YH; Yue, SW; Zhang, Y | 1 |
Bendhack, LM; Bonaventura, D; da Silva, RS; de Lima, RG | 1 |
6 other study(ies) available for ruthenium and cyclic gmp
Article | Year |
---|---|
Highly selective binding of organometallic ruthenium ethylenediamine complexes to nucleic acids: novel recognition mechanisms.
Topics: Adenosine; Adenosine Monophosphate; Cyclic GMP; Ethylenediamines; Guanosine Monophosphate; Inosine; Inosine Monophosphate; Kinetics; Nuclear Magnetic Resonance, Biomolecular; Nucleic Acids; Nucleosides; Nucleotides; Organometallic Compounds; Ruthenium; Substrate Specificity; Thymidine Monophosphate | 2003 |
Competition between glutathione and guanine for a ruthenium(II) arene anticancer complex: detection of a sulfenato intermediate.
Topics: Antineoplastic Agents; Binding, Competitive; Cyclic GMP; Glutathione; Guanine; Hydrogen-Ion Concentration; Nuclear Magnetic Resonance, Biomolecular; Organometallic Compounds; Ruthenium; Water | 2005 |
Characterization of the mechanisms of action and nitric oxide species involved in the relaxation induced by the ruthenium complex.
Topics: Animals; Cells, Cultured; Cyclic GMP; Free Radical Scavengers; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide; Potassium Channel Blockers; Rats; Rats, Wistar; Ruthenium | 2006 |
Biological activity of designed photolabile metal nitrosyls: light-dependent activation of soluble guanylate cyclase and vasorelaxant properties in rat aorta.
Topics: Animals; Aorta; Cells, Cultured; Cyclic GMP; Enzyme Activation; Guanylate Cyclase; In Vitro Techniques; Iron; Light; Manganese; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nitric Oxide Donors; Organometallic Compounds; Rats; Receptors, Cytoplasmic and Nuclear; Ruthenium; Soluble Guanylyl Cyclase; Structure-Activity Relationship; Vasodilation; Vasodilator Agents | 2006 |
Involvement of TRPV4-NO-cGMP-PKG pathways in the development of thermal hyperalgesia following chronic compression of the dorsal root ganglion in rats.
Topics: Animals; Behavior, Animal; Cyclic GMP; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Ganglia, Spinal; Hyperalgesia; Male; Nitric Oxide; Nitrites; Oligodeoxyribonucleotides, Antisense; Pain Threshold; Protein Kinase C; Radiculopathy; Rats; Rats, Wistar; Ruthenium; Signal Transduction; Statistics, Nonparametric; TRPV Cation Channels | 2010 |
NO donors-relaxation is impaired in aorta from hypertensive rats due to a reduced involvement of K(+) channels and sarcoplasmic reticulum Ca(2+)-ATPase.
Topics: Animals; Aorta; Cyclic GMP; Guanylate Cyclase; Hypertension; Hypertension, Renal; Male; Nitric Oxide Donors; Nitroprusside; Organometallic Compounds; Potassium Channel Blockers; Potassium Channels; Rats; Rats, Wistar; Ruthenium; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Vasodilation | 2011 |